US 9567588
Modulation of androgen receptor expression
granted A61KA61K31/4166A61K31/7088
Quick answer
US patent 9567588 (Modulation of androgen receptor expression) held by Ionis Pharmaceuticals, Inc. expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/4166, A61K31/7088, A61P, A61P13/08